PI3K/AKT/mTOR Pathway Mutation
1 clinical trials · Condition
◉ Watch PI3K/AKT/mTOR Pathway Mutation
| Record | Firm | Date |
|---|---|---|
| Efficacy of Everolimus-containing Chemotherapy in HER2- mBC Patients With PI3K/AKT/mTOR Mutations Study (NCT05054166) | Zhejiang Cancer Hospital | 2021-05-01 |
Track PI3K/AKT/mTOR Pathway Mutation automatically
Every clearance here is in the API, with alerts when new ones post.